Reuters logo
Merck's revenue rises 1.3 pct
May 2, 2017 / 10:53 AM / in 7 months

Merck's revenue rises 1.3 pct

May 2 (Reuters) - Merck & Co Inc reported a 1.3 percent rise in quarterly revenue, helped by higher demand for its key immuno-oncology drug Keytruda.

Net income attributable to Merck rose to $1.55 billion, or 56 cents per share, in the first quarter, from $1.13 billion, or 40 cents per share, a year earlier.

Total revenue climbed to $9.43 billion from $9.31 billion. (Reporting by Natalie Grover; Editing by Savio D‘Souza)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below